- Investing Ideas
- Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
5
Value score of at least 4 focused on companies with a low market cap.
5 companies
PhoenixBio
Market Cap: JP¥1.6b
Provides contract testing services for medical product development in Japan, the United States, and internationally.
6190
JP¥396.00
7D
-9.8%
1Y
2.6%
Linical
Market Cap: JP¥4.9b
A global contract research organization provides full spectrum of drug development services to pharmaceutical companies worldwide.
2183
JP¥219.00
7D
-0.9%
1Y
-31.1%
Kidswell Bio
Market Cap: JP¥7.4b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥150.00
7D
-9.6%
1Y
-34.5%
Immuno-Biological Laboratories
Market Cap: JP¥9.4b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥1,012.00
7D
-9.1%
1Y
94.2%
WDB coco
Market Cap: JP¥6.2b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,570.00
7D
0.6%
1Y
-17.0%